MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathway
Chikungunya virus (CHIKV) epidemics around the world have created public health concern with the unavailability of effective drugs and vaccines. This emphasizes the need for molecular understanding of host-virus interactions for developing effective targeted antivirals. Microarray analysis was carri...
Enregistré dans:
Auteurs principaux: | Prabhudutta Mamidi, Tapas Kumar Nayak, Abhishek Kumar, Sameer Kumar, Sanchari Chatterjee, Saikat De, Ankita Datey, Soumyajit Ghosh, Supriya Suman Keshry, Sharad Singh, Eshna Laha, Amrita Ray, Subhasis Chattopadhyay, Soma Chattopadhyay |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fbfa341d712c4abd9c6213d86efad4e1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathway.
par: Prabhudutta Mamidi, et autres
Publié: (2021) -
VIPER regulates naive T cell activation and effector responses: Implication in TLR4 associated acute stage T cell responses
par: Subhransu Sekhar Sahoo, et autres
Publié: (2018) - MK - Marketing más Ventas
-
Classification of Abrogation in the Qur’an
par: Israr Ahmad Khan
Publié: (2006) -
A social engineering model for poverty alleviation
par: Amit K. Chattopadhyay, et autres
Publié: (2020)